Application of the Altshock-2 randomized trial enrollment criteria to the Altshock-2 registry population: are we missing someone?

Back

ESC Professional Premium Access

Application of the Altshock-2 randomized trial enrollment criteria to the Altshock-2 registry population: are we missing someone?

Session: Device therapy in acute heart failure and cardiogenic shock

Topic: Nonpharmacological Treatment

Speaker: Doctor M. Milani (Lecco, IT)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Martina Milani

Alessandro Manzoni Hospital, Lecco (Italy)

1 presentation

0 follower

6 more presentations in this session

MCS current practice and weaning: CCCTN survey of CICU directors at academic medical centers

Speaker: Doctor A. Balgobind (Bronx, US)

The effect of intra-aortic balloon pumping on hemodynamics and left ventricular load in Impella-supported condition: A simulation study

Speaker: Mr H. Matsushita (Suita, JP)

The role of continuous ultrafiltration in severely ill patients admitted with acutely decompensated congestive heart failure and diuretic resistance

Speaker: Doctor E. Mantzouranis (Athens, GR)

Characteristics and outcomes of combination VA-ECMO for cardiogenic shock

Speaker: Associate Professor J. Hernandez-Montfort (Temple, US)

Cardiogenic shock complicating acute myocardial infarction; mechanical circulatory support use in the Netherlands.

Speaker: Miss M. Bogerd (Amsterdam, NL)

Access the full session

Device therapy in acute heart failure and cardiogenic shock

Speakers: Doctor M. Milani, Doctor A. Balgobind, Mr H. Matsushita, Doctor E. Mantzouranis, Associate Professor J. Hernandez-Montfort...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources